411 results on '"Ronchi, Cristina L"'
Search Results
2. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports
3. Inflammation-based scores in patients with pheochromocytoma
4. Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma: Diagnosis, prevalence, and clinical impact
5. Role of ccfDNA-based biomarkers in classification of adrenocortical adenomas
6. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
7. Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation.
8. Single‐nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoural adrenal glands.
9. Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?
10. Next-generation therapies for adrenocortical carcinoma
11. Cellular Landscape of Adrenocortical Carcinoma at Single-Nuclei Resolution
12. Genomic and sequence variants of protein kinase A regulatory subunit type 1β (PRKAR1B) in patients with adrenocortical disease and Cushing syndrome
13. High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study
14. Inflammation-based Scores In Benign Adrenocortical Tumours Are Linked To The Degree Of Cortisol Excess - a retrospective single centre study
15. PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma
16. cAMP/protein kinase A signalling pathway and adrenocortical adenomas
17. Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma.
18. Cellular landscape of adrenocortical carcinoma at single-nuclei resolution
19. Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study
20. Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment
21. Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
22. Pheochromocytomas Most Commonly Present As Adrenal Incidentalomas: A Large Tertiary Center Experience.
23. COVID‐19‐related adrenal haemorrhage: Multicentre UK experience and systematic review of the literature
24. PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma
25. Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma
26. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
27. A case of unilateral post-COVID-19 adrenal haemorrhage and follow-up during pregnancies
28. Approach to the Patient With Adrenal Hemorrhage
29. Additional file 1 of Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports
30. Pheochromocytomas Most Commonly Present As Adrenal Incidentalomas: A Large Tertiary Center Experience
31. Adrenal disorders: Is there Any role for vitamin D?
32. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept
33. Inflammation-Based Scores as Predictors of Treatment Response in Advanced Adrenocortical Carcinoma
34. Cell Atlas at Single-Nuclei Resolution of the Adult Human Adrenal Gland and Adrenocortical Adenomas
35. Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma
36. Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
37. Correction to: Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
38. Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas
39. Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
40. MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma
41. Transcriptome in paraffin samples for the diagnosis and prognosis of adrenocortical carcinoma
42. Approach to the Patient With Adrenal Hemorrhage.
43. Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers
44. The role of molecular profiling in adrenocortical carcinoma
45. Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning
46. Adrenocortical tumors and insulin resistance: What is the first step?
47. Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells
48. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
49. Should the 1 mg -overnight dexamethasone suppression test be repeated in patients with benign adrenal incidentalomas and no overt hormone excess?
50. Complex management of unilateral post-Covid-19 adrenal haemorrhage during pregnancy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.